跳至主要内容
临床试验/NCT04132934
NCT04132934已完成不适用

Observational Study Program Assessing Effectiveness and Tolerability of Gliclazide MR 60mg in Patients With Type 2 Diabetes Fasting During RAMADAN

Servier Affaires Médicales1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2019年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,200
试验地点
1
主要终点
Proportion of patients with at least one Hypoglycemia event

研究概览

简要总结

The purpose of this observational study is to assess effectiveness and tolerability of gliclazide MR 60mg during RAMADAN in a real world setting in 9 countries from Asia Pacific and Middle East/North Africa

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent obtained before any trial-related activities
  • Male or female type 2 diabetic patients aged >18 years
  • Patients with controlled or suboptimal controlled type 2 diabetes
  • Patients with experience in SMBG controlling using glucometer
  • Patients who are willing to fast during Ramadan
  • Patients already treated with Gliclazide MR 60mg

排除标准

  • Insulin therapy requirement
  • Severe liver or renal failure
  • HbA1c ≥ 9%
  • Contraindication to gliclazide according to SmPC
  • Pregnancy or breast feeding
  • Previous experience of severe or repeated hypoglycemia events without triggered factor within the previous year

结局指标

主要结局

Proportion of patients with at least one Hypoglycemia event

时间窗: up to 5 months

次要结局

未报告次要终点

研究者

发起方
Servier Affaires Médicales
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验